当前位置:首页 - 行情中心 - 特宝生物(688278) - 财务分析

特宝生物

(688278)

  

流通市值:241.24亿  总市值:241.24亿
流通股本:4.08亿   总股本:4.08亿

特宝生物(688278)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.64亿元,每股收益0.40元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益363038.60万元,未分配利润247145.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产446340.90万元,负债83302.30万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入797,791,349.653,695,567,867.632,479,547,947.461,510,615,117.77
营业总成本608,608,067.392,481,201,979.551,721,216,914.121,025,083,005.41
其他经营收益
营业利润198,634,338.151,250,642,983.79781,386,853.42497,149,474.06
利润总额179,040,129.531,175,374,781.05730,997,712.61476,272,103.72
净利润164,494,475.211,031,236,252.58666,123,781.87427,894,111.21
每股收益
其他综合收益---81,743.32-
综合收益总额164,494,475.211,031,236,252.58666,042,038.55427,894,111.21
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,785,239,490.762,730,375,042.652,234,609,651.071,869,679,350.53
非流动资产:
非流动资产合计1,678,169,473.941,643,145,577.891,551,638,564.121,339,687,744.03
资产总计4,463,408,964.74,373,520,620.543,786,248,215.193,209,367,094.56
流动负债:
流动负债合计581,301,007.88707,113,916.83581,467,931.59359,793,134.05
非流动负债:
非流动负债合计251,721,991.3216,828,051.17195,520,357.4594,187,098.66
负债合计833,022,999.18923,941,968776,988,289.04453,980,232.71
所有者权益(或股东权益):
归属于母公司股东权益合计3,630,385,965.523,449,578,652.543,009,259,926.152,755,386,861.85
股东权益合计3,630,385,965.523,449,578,652.543,009,259,926.152,755,386,861.85
负债和股东权益合计4,463,408,964.74,373,520,620.543,786,248,215.193,209,367,094.56
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,000,052,048.523,410,862,326.352,486,230,477.481,629,731,457.08
经营活动现金流出小计865,669,840.762,681,486,457.492,015,112,270.781,269,186,044.61
经营活动产生的现金流量净额134,382,207.76729,375,868.86471,118,206.7360,545,412.47
投资活动产生的现金流量:
投资活动现金流入小计611,148,536.581,560,173,356.511,047,660,067.17846,895,967.36
投资活动现金流出小计341,873,480.22,060,504,603.021,347,030,768.27793,678,266.44
投资活动产生的现金流量净额269,275,056.38-500,331,246.51-299,370,701.153,217,700.92
筹资活动产生的现金流量:
筹资活动现金流入小计41,500,000195,110,178.6174,439,826.410,000,000
筹资活动现金流出小计31,647,131.23262,268,038.98258,357,766.87256,782,310.72
筹资活动产生的现金流量净额9,852,868.77-67,157,860.38-83,917,940.47-246,782,310.72
汇率变动对现金及现金等价物的影响-24,947.16-549,425.9-201,057.26170,763.63
现金及现金等价物净增加额413,485,185.75161,337,336.0787,628,507.87167,151,566.3
期末现金及现金等价物余额936,338,220.25522,853,034.5449,144,206.3528,667,264.73
补充资料:
现金及现金等价物的净增加额-161,337,336.07-167,151,566.3
最新报告期:2026-04-17
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
国泰海通彭娉,郑琴,余文心,廖博闻3.224.095.102026-04-17
兴业证券孙媛媛,杨希成,黄翰漾3.043.654.422026-04-15
西部证券李梦园3.274.265.132026-04-13
国海证券年庆功3.324.295.412026-04-01
国信证券彭思宇,陈曦炳,马千里3.164.225.392026-04-01
TOP↑